Sort   by:  
 Page size 
UnknownManagement of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance.
Not available
S-EPMC7283207 | biostudies-literature
UnknownMeta-analysis on the association of VEGFR1 genetic variants with sunitinib outcome in metastatic renal cell carcinoma patients.
Not available
S-EPMC5352048 | biostudies-literature
UnknownPrognostic Value and Clinical Significance of FGFR Genomic Alterations (GAs) in Metastatic Urothelial Cancer Patients.
Not available
S-EPMC9369263 | biostudies-literature
UnknownAssociation of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma.
Not available
S-EPMC4643117 | biostudies-literature
UnknownGender influence on work satisfaction and leadership for medical oncologists: a survey of the Spanish Society of Medical Oncology (SEOM).
Not available
S-EPMC7872979 | biostudies-literature
UnknownSafety and efficacy of the tumor-selective adenovirus enadenotucirev with or without paclitaxel in platinum-resistant ovarian cancer: a phase 1 clinical trial.
Not available
S-EPMC8666888 | biostudies-literature
UnknownPemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trial.
Not available
S-EPMC11186762 | biostudies-literature
UnknownPBRM1 and KDM5C cooperate to define high-angiogenesis tumors and increased antiangiogenic response in renal cancer.
Not available
S-EPMC10244090 | biostudies-literature
UnknownEpithelial-to-Mesenchymal Transition Mediates Resistance to Maintenance Therapy with Vinflunine in Advanced Urothelial Cell Carcinoma.
Not available
S-EPMC8699401 | biostudies-literature
UnknownMicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome and repression of specific mRNA targets.
Not available
S-EPMC7485767 | biostudies-literature
Sort   by:  
 Page size